Phenytoin-valproate Interaction:Importance of Saliva Monitoring in Epilepsy
BMJ 284:13-16, Knott,C.,et al, 1982
Risk Factors of Hyperammonemia in Patients with Epilepsy Under Valproic Acid Therapy
Medicine 93:e66, Tseng, Y.L.,et al, 2014
Chitosan May Decrease Serum Valproate and Increase Risk of Seizure Reappearance
BMJ 339:a2163, Striano,P.,et al, 2009
Major Malformations in Offspring of Women with Epilepsy
Neurol 60:575-579, Kaaja,E.,et al, 2003
Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate
Neurol 54:230-232, Hamer,H.M.,et al, 2000
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Antiepileptic Drugs
NEJM 334:168-175, Brodie,M.J.&Dichter,M.A., 1996
Valproic Acid-Induced Hyperammonemic Encephalopathy:MR Appearance
AJNR 15:1779-1781, Baganz,M.D.&Dross,P.E., 1994
Comparison of Sprinkle Versus Syrup Formulations of Valproate for Bioavailability, Tolerance, and Preference
J Pediatr 120:634-638, Cloyd,J.C.,et al, 1992
Valproate-Induced Coma with Ketosis and Carnitine Insufficiency
Arch Neurol 47:1131-1133, Triggs,W.J.,et al, 1990
Effect of Food on the Serum Concentration Profile of Enteric-Coated Valproic Acid
Neurol 38:1319-1322, Fischer,J.H.,et al, 1988
Breakthrough Seizure Following Substitution of Depakene Capsules with a Generic Product
Neurol 37:1885, MacDonald,J.T., 1987
Plasma Concentrations of Sodium Valproate:Their Clinical Value
Ann Neurol 14:38-42, Turnbull,D.M.,et al, 1983
Valproic Acid
NEJM 302:661-666, Brown,T.R., 1980
Protein Binding of Valproic Acid in Uremic Patient
Neurol 30:557-559, Bruni,J.,et al, 1980
Valproic Acid & Ethosuximide Interaction
Ann Neurol 7:583-584, Mattson,R.H.,et al, 1980
Valproic Acid, Review of a New Antiepileptic Drug
Arch Neurol 36:393-398, Bruni,J.,et al, 1979
Treatment of Accidental Sodium Valproate Overdose with an Opiate Antagonist
Ann Neurol 6:274, Steiman,G.S.,et al, 1979
Acute Intoxication with Sodium Valproate
Ann Neurol 6:552-553, Chadwick,D.W.,et al, 1979
Valproic Acid in Epilepsy:Clinical & Pharmacological Effects
Ann Neurol 3:20, Mattson,R.H.,et al, 1978
Sodium Valproate in the Treatment of Intractable Seizure Disorders:A Clinical & Electroencephalographic Study
Neurol 28:152, Adams,D.,et al, 1978
Valproic Acid:Interaction with Other Anticonvulsant Drugs
Neurol 28:892-896, Wilder,B.J.,et al, 1978
Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary
Neurol 98:31-43, Price, R.,et al, 2022
The SANAD II Study of the Effectiveness and Cost-Effectiveness of Valproate Versus Levetiracetam for Newly Diagnosed Generalised and Unclassifiable Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1375-1386, Marson, A.,et al, 2021
Initial Management of Seizure in Adults
NEJM 385:251-263, Smith, P.E.M., 2021
Choosing Anticonvulsant Medications to Manage Status Epilepticus
NEJM 382:2569-2572, Wu, K., 2020
Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs with Risk for Attention-Deficit/Hyperactivity Disorder in Offspring
JAMA Netw Open 2:e186606, Christensen, J.,et al, 2019
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Risk of 23 Specific Malformations Associated with Prenatal Exposure to 10 Antiepileptic Drugs
Neurol 93:e167-e180, Blotiere, P.O.,et al, 2019
Declining Malformation Rates with Changed Antiepileptic Drug Prescribing, An Observational Study
Neurol 93:e831-e840, Tomson,T.,et al, 2019
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
NEJM 381:2103-2113,2171, Kapur, J.,et al, 2019
A 22-year-old Man Presenting with Headache and Right Leg Jerks
Neurol 91:891-895, Schupper, A.J.,et al, 2018
Maternal Use of antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children
JAMA 318:1700-1701, Bromley, R.L.,et al, 2017
Clinicopathologic Conference, Copper Deficiency Myelopathy
NEJM 377:1977-1984, Case 35-2017, 2017
Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
JAMA 309:1696-1703, Christensen, J.,et al, 2013
Weight Change Associated with Antiepileptic Drugs
JNNP 84:796-799, Pickrell, W.,et al, 2013
Effects of Fetal Antiepileptic Drug Exposure
Neurol 78:1207-1214, Meador,K.J.,et al, 2012
Substitution Monotherapy with Levetiracetam vs Older Antiepileptic Drugs
Arch Neurol 69:1563-1571, Hakami, T.,et al, 2012
Child Development Following In Utero Exposure: Levetiracetam vs Sodium Valproate
Neurol 76:383-389, Shallcross,R.,et al, 2011
Fetal Effects of Anticonvulsant Polytherapies
Arch Neurol 68:1273-1279, Holmes, L.et al, 2011
Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
NEJM 362:790-799, Glauser,T.A.,et al, 2010
Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations
NEJM 362:2185-2193, Jentink,J., et al, 2010
Cognitive Function at 3 Years of Age After Fetal Exposure to Antiepileptic Drugs
NEJM 360:1597-1605,1667, Meador,K.J.,et al, 2009
Bone Health in Young Women With Epilepsy After One Year of Antiepileptic Drug Monotherapy
Neurol 70:1586-1593, Pack,A.M.,et al, 2008
Autism Spectrum Disorders Following In Utero Exposure to Antiepileptic Drugs
Neurol 71:1923-1924, Bromley,R.I.,et al, 2008
Randomized Study of Intravenous Valproate and Phenytoin in Status Epilepticus
Seizure 16:527-532, Agarwal,P.,et al, 2007
Intravenous Sodium Valproate Versus Diazepam Infusion for the Control of Refractory Status Epilepticus in Children: A Randomized Controlled Trial
J Child Neurol 22:1191-1197, Mehta,V.,et al, 2007
Malformation Risks of Antiepileptic Drugs in Pregnancy: A Prospective Study from the UK Epilepsy and Pregnancy Register
JNNP 77:193-198,145, Morrow,J.,et al, 2006
Prenatal Exposure to Antiepileptic Drugs
Lancet 367:1467-1469, Perucca,E. &Tomson,T., 2006